The neuromuscular blocking properties of the antimalarial agent, bis((chloro-7"-quinolyl-4")amino-2'-propyl)-1,4-piperazine.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001049:Apnea / Q000139:chemically induced; D002118:Calcium / Q000494:pharmacology; D002738:Chloroquine / Q000494:pharmacology; D003964:Diaphragm / Q000187:drug effects; D004558:Electric Stimulation; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D010710:Phosphates / Q000494:pharmacology; D010791:Phrenic Nerve / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012584:Sciatic Nerve / Q000187:drug effects; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D000962:Antimalarials; D009467:Neuromuscular Depolarizing Agents; D010710:Phosphates; D010879:Piperazines; D002738:Chloroquine; D008274:Magnesium; D013390:Succinylcholine; D000109:Acetylcholine; D011188:Potassium; D002118:Calcium; D014403:Tubocurarine